2025 ACC/AHA/HRS/ISACHD/SCAI 成人先天性心脏病管理指南
该指南由ACC/AHA联合委员会制定,基于2017至2024年文献综述,更新2018版成人先天性心脏病管理指南,为临床医生提供评估与治疗推荐。
要点
- 新指南整合2017–2024年新证据,替代2018版成人先天性心脏病指南。
- 推荐用于成人先天性心脏病患者的评估与治疗决策。
- 基于多数据库系统检索,纳入临床研究、系统评价和荟萃分析。
核心结论
- 指南更新了成人先天性心脏病管理的推荐,以新证据指导临床实践。
研究设计与样本
- 制定机构为ACC/AHA联合委员会,并联合HRS、ISACHD、SCAI。
- 通过MEDLINE、EMBASE、Cochrane Library等数据库进行全面文献检索,重点为2017至2024年发表的文献。
临床怎么用
- 临床医生可依据该指南对成人先天性心脏病患者进行评估和治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The "2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease" provides recommendations to guide clinicians on the evaluation and treatment of adult patients with congenital heart disease. It incorporates new evidence to replace the "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease." METHODS: A comprehensive literature search was conducted with a focus on literature published from 2017 to 2024; in some instances, older literature was also collected and reviewed. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants and published in English were identified from MEDLINE (via PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and CINAHL for selected searches. STRUCTURE: Recommendations from the "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease" have been updated with new evidence to guide clinicians.
引用
- Gurvitz, Krieger, Fuller, et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025. PMID: 41411375. doi:10.1161/CIR.0000000000001402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。